After rats were euthanized, the brain and trigeminal ganglia were extracted and rinsed in cold Hanks' balanced salt solution (HBSS; Invitrogen, Life Technologies, Carlsbad, CA). TG cells were prepared according to a previously reported method with modifications.
10 Briefly, the trigeminal ganglia were minced with scissors and digested for 30 minutes with 3 mg/mL collagenase A (Roche Diagnostics, Basel, Switzerland), and then incubated for 40 minutes in neuronal dispersion liquid (Sumitomo Bakelite, Tokyo, Japan) at 37°C. Following filtration through a 40-μm cell strainer (Becton Dickinson, Franklin Lakes, NJ), 10% BSA solution was added, and the cells were pelleted by centrifugation (30 minutes, 1000
g). Mixed TG cells containing neurons and glial cells were seeded at 2.5 × 10
3 neuronal cells/well into 8-well dishes or at 2.0 × 10
3 neuronal cells/well into 35-mm glass-bottom dishes, coated with poly-D-lysine and laminin (Becton Dickinson). The culture medium was neurobasal medium (NB, Invitrogen) supplemented with B-27 (Invitrogen); 1 mM L-glutamine (Invitrogen); primocin (InvivoGen, San Diego, CA); and 10 μM cytosine β-D-arabinofuranoside (Ara-C; Wako, Osaka, Japan). The cells were cultured for 24 hours with or without FK962 (kindly provided by Astellas Pharma Inc., Tokyo, Japan) at 37°C under 5% CO
2 and 95% air. The cells were also treated with GDNF, SST (Merck, Darmstadt, Germany) or NGF (R&D Systems, Minneapolis, MN). Goat GDNF antibody (R&D Systems) at 1 μg/mL or goat NGF antibody (Abcam, Cambridge, UK) at 0.3 μg/mL were used to inhibit GDNF-, NGF-, and FK962-induced elongation, with normal goat IgG (Santa Cruz Biotechnology, Santa Cruz, CA) at 1 μg/mL or at 0.3 μg/mL used as a negative controls. For qPCR, mixed TG cells were seeded at 2.8 × 10
4 neuronal cells/well into 6-well dishes and cultured for 17 hours under the condition described above.